BioCentury
ARTICLE | Clinical News

SUVN-502: Phase I start

June 23, 2008 7:00 AM UTC

Suven began a single and multiple ascending-dose, Swiss Phase I trial to evaluate oral SUVN-502 in 67 healthy volunteers. ...